Johnson Matthey (LON:JMAT – Get Free Report) had its price objective upped by equities research analysts at Berenberg Bank from GBX 2,300 to GBX 2,550 in a report released on Wednesday, Digital Look reports. The firm currently has a “buy” rating on the stock. Berenberg Bank‘s price objective would indicate a potential upside of 5.28% from the stock’s current price.
Several other research analysts have also recently issued reports on the stock. Jefferies Financial Group restated a “buy” rating and issued a GBX 2,330 target price on shares of Johnson Matthey in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 2,400 price target on shares of Johnson Matthey in a research report on Monday, July 6th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of GBX 2,370.
View Our Latest Analysis on JMAT
Johnson Matthey Price Performance
Insider Buying and Selling
In related news, insider Alastair Judge acquired 12 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was acquired at an average cost of GBX 2,193 per share, for a total transaction of £263.16. Also, insider Liam Condon bought 10,951 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were bought at an average cost of GBX 2,306 per share, for a total transaction of £252,530.06. Insiders acquired 28,608 shares of company stock valued at $64,947,512 over the last quarter. 0.77% of the stock is owned by company insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
